Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 19 of 19 publications.

Shamarina D, Sluga-O'Callaghan M, Dave V, Davenport E, Curran D, Deeywadaa P, Marijam A, Andani A. Knowledge and attitudes of European HCPs towards hepatitis A and B vaccination of adults at risk. Poster presented at the Global Hepatitis Summit 2023; April 25, 2023. Paris, France. Previously presented at the 15th European Public Health Conference 2022 (EPH).

Grivas P, Barata PC, Moon H, Hutson TE, Gupta S, Sternberg CN, Dave V, Downey C, Shillington AC, Devgan G, Kirker M, Thakkar S, Katzenstein HM, Bhanegaonkar A, Liu F, Brown J, Sonpavde GP. Baseline characteristics from a retrospective, observational, US-based, multicenter, real-world (RW) study of avelumab first-line maintenance (1LM) in locally advanced/metastatic urothelial carcinoma (la/mUC) (PATRIOT-II). Poster presented at the 2023 ASCO Genitourinary Cancers Symposium; February 16, 2023. San Francisco, CA. [abstract] J Clin Oncol. 2023 Feb 1; 41(Suppl 4). doi: 10.1200/JCO.2023.41.6_suppl.465

Gogate A, Shillington AC, Dave V, Singh P. First- and second-line treatment patterns in recurrent or metastatic squamous cell carcinoma of the head and neck: a chart review study in three countries. Poster presented at the ISPOR Europe 2022; November 6, 2022. Vienna, Austria. [abstract] Value Health. 2022 Dec 1; 25(12):S287. doi: 10.1016/j.jval.2022.09.1416

Shamarina D, Sluga-O'Callaghan M, Dave V, Davenport E, Curran D, Marijam A, Andani A. Knowledge and attitudes of European HCPs towards hepatitis A and B vaccination of adults at risk. Poster presented at the 15th European Public Health Conference 2022 (EPH); November 9, 2022. Berlin, Germany.

Grivas P, Barata PC, Moon H, Hutson TE, Gupta S, Sternberg CN, Pickard AS, Dave V, Han N, Shillington AC, Devgan G, Kim R, Thakkar S, Katzenstein H, Bhanegaonkar A, Liu F, Sonpavde GP. PATRIOT II: an ambispective, observational, multicenter, 2-cohort study of avelumab (Ave) first-line maintenance (1LM) in locally advanced/metastatic urothelial carcinoma (la/mUC) in the United States. Poster presented at the 2022 ASCO Annual Meeting; June 3, 2022. Chicago, IL. [abstract] J Clin Oncol. 2022 Jun 1; 40(Supple 6). doi: 10.1200/JCO.2022.40.6_suppl.TPS578 Journal of Clinical Oncology 40, no. 6_suppl

Johnson N, Paradis AD, Dave V, Macahilig C, Johnson C, Stephens JM, Atzinger C. Healthcare resource use and activities of daily living status among adult patients with spinal muscular atrophy: a natural history multicountry chart review study. Poster presented at the Virtual ISPOR Europe 2021; November 2021. [abstract] Value Health. 2021 Dec; 24(12):S2.

Singh P, Contente M, Shillington A, Dave V, Kiff C, Cotte FE, Macahilig C. Treatment and outcomes in recurrent metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): a chart review study in France, Germany and the United Kingdom. Poster presented at the Virtual ISPOR 2020 Conference; November 2020. [abstract] Value Health. 2020 Dec 1; 23(Supplement 2):S427. doi: 10.1016/j.jval.2020.08.172

Joseph RW, Liu FX, Shillington AC, Macahilig CP, Diede SJ, Dave V, Harshaw Q, Saretsky TL, Pickard AS. Health-related quality of life (QoL) in patients with advanced melanoma receiving immunotherapies in real-world clinical practice settings. Qual Life Res. 2020 Oct;29(10):2651-60. doi: 10.1007/s11136-020-02520-7

Joseph RW, Shillington AC, Lee TA, Macahilig CP, Diede SJ, Dave V, Harshaw Q, Scherrer E, Liu FX. Hospitalization and emergency department utilization in patients with advanced melanoma receiving pembrolizumab versus ipilimumab plus nivolumab in US academic centers. J Med Econ. 2020 Feb;23(2):132-8. doi: 10.1080/13696998.2019.1696349

Joseph RW, Shillington AC, Lee T, Macahilig C, Diede SJ, Dave V, Harshaw Q, Taymor E, Liu FX. Health care resource utilization in patients with advanced melanoma receiving immunotherapies in the real world. J Clin Oncol. 2019 May;37(15_suppl):9532.

Joseph RW, Shillington AC, Macahilig C, Diede SJ, Dave V, Harshaw Q, Liu FX. Factors associated with immunotherapy selection in patients with advanced melanoma. Immunotherapy. 2018 Nov;10(16):1361-9. doi: 10.2217/imt-2018-0150

Joseph RW, Shillington A, Macahilig C, Diede SJ, Dave V, Harshaw Q, Liu FX. Factors predicting the use of immunotherapy for patients with advanced melanoma. Poster presented at the 2018 ASCO Annual Meeting; May 2018. [abstract] J Clin Oncol. 2018 May 20; 36(15_Suppl). doi: 10.1200/JCO.2018.36.15_suppl.9571

Apostolou A, Bolcen SJ, Dave V, Jani N, Lasker BA, Tan CG, Montana B, Brown JM, Genese CA. Nocardia cyriacigeorgica infections attributable to unlicensed cosmetic procedures--an emerging public health problem? Clin Infect Dis. 2012 Jul;55(2):251-3. doi: 10.1093/cid/cis341

Apostolou A, Dave V, Jani N, Bolcen S, Lasker BA, Tan CG, Montana B, Genese CA. Nocardia cyriacigeorgica infections associated with cosmetic injections, New Jersey, 2010. Poster presented at the 2010 48th Annual Meeting Infectious Disease Society of America (IDSA); October 22, 2010. Vancouver, Canada.

Vyas (Dave) VH, Demissie K, Rhoads GG. Cancer incidence among Asian Indian migrants, 1988-1997. Poster presented at the 2001 American Society of Clinical Oncoology Annual Cancer Retreat; April 25, 2001. Princeton, NJ.

Pandya DP, Vyas (Dave) VH, Vyas SH. Mind-body therapy in the management and prevention of coronary disease. Compr Ther. 1999 May;25(5):283-93. doi: 10.1007/BF02944271

Parmer TG, Ward MD, Yurkow EJ, Vyas (Dave) VH, Kearney TJ, Hait WN. Activity and regulation by growth factors of calmodulin-dependent protein kinase III (elongation factor 2-kinase) in human breast cancer. Br J Cancer. 1999 Jan;79(1):59-64. doi: 10.1038/sj.bjc.6690012

Julius, Jr P, Kaga M, Palmer Y, Vyas (Dave) V, Prior L, Delice D, Riggs J. Recipient age determines the success of intraperitoneal transplantation of peritoneal cavity B cells. Immunology. 1997 Jul;91(3):383-90. doi: 10.1046/j.1365-2567.1997.00270.x

Riggs J, Vyas (Dave) V, Kaga M, Julius P, Delice D, Palmer Y. Age dependent restriction of peritoneal cavity B cell access to circulation. Poster presented at the 1997 American Association of Immunologists Conference; February 1997. San Francisco, CA.